Prognostic factors in patients with submucosal carcinoma of the oesophagus by Watanabe, M et al.
Recent advances in diagnostic techniques have facilitated in the
early detection of gastrointestinal carcinomas and have also
contributed to the improvement of treatment results. Patients
presenting with superficial oesophageal carcinoma limited to
within the submucosal (sm) layer have also increased in recent
years (Yoshinaka et al, 1991; Sugimachi et al, 1993), owing to the
popularization of panendoscope and Lugol’s solution staining
techniques (Brodmerkel, 1971; Sugimachi et al, 1989).
The treatment results of patients with mucosal carcinoma of the
oesophagus have been reported to be favourable, and then an
endoscopic mucosal resection has been considered to be indicated
for epithelial and lamina propria mucosae cancers (Akiyama et al,
1994a; Kodama and Kakegawa, 1998). In contrast, the prognosis
of patients with advanced oesophageal cancer is still poor contrary
to the efforts such as an extended lymphadenectomy (Isono et al,
1991). Recently, multimodal treatment including chemotherapy,
irradiation and hyperthermia has been indicated for cases with
locally advanced tumours (Lehnert, 1999).
Although the prognosis of patients with sm carcinoma has been
reported to be significantly superior to that with advanced carci-
noma, it remains still unsatisfactory (Sugimachi et al, 1991;
Kitamura et al, 1993; Nabeya and Nakata, 1997). There have been
still more than a few patients who died of recurrent carcinoma,
especially due to distant organ metastasis (Watanabe et al, 1995),
even when a curative oesophagectomy had been performed. In
such cases, the carcinoma should be considered to be a systemic
disease at the time of the operation, and that it is impossible to cure
them by radical surgery alone. Therefore, it is necessary to select a
group of patients who have a high risk of recurrence and to admin-
ister an adequate adjuvant therapy. However, only a few attempts
have so far been made at identifying types of tumour have a high
risk of recurrence.
The aim of this study is to clarify the prognostic factors in
patients with sm carcinoma of the oesophagus, using a univariate
and multivariate analysis on 78 patients who had been operated on
over the past decade.
PATIENTS AND METHODS
Patients
From 1988–1997, 397 patients with oesophageal carcinoma
underwent an oesophagectomy at the Department of Surgery II,
Kyushu University Hospital. Among these patients, 116 (29.2%)
had superficial oesophageal cancer, including 6 intraepithelial, 32
mucosal and 78 sm carcinomas. All 78 patients with sm carcinoma
who underwent an oesophagectomy with lymph node dissection
were investigated.
Histological examination
All the resected specimens, including the lymph nodes, were
histopathologically examined. Microscopic sections of the entire
resected oesophagus were prepared from step-sectioned blocks,
measuring 5 mm in width, after staining with haematoxylin and
eosin, and such histological features as the depth and extent of the
lesions, involvement to either the lymphatic or blood vessels,
intramural metastasis and lymph node metastasis were evaluated.
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doi: 10.1054/ bjoc.2000.1288, available online at http://www.idealibrary.com on Pathologic diagnosis and classification were made according to
Guidelines for the Clinical and Pathologic Studies on Carcinoma
of the Esophagus (Japanese Society for Esophageal Diseases,
1999). The depth of penetration was subclassified into 3 grades;
namely sm1, sm2 and sm3 (Nabeya and Nakata, 1997). Sm1 is
defined as one-third invasion in the superficial submucosal layer,
sm2 as one-third invasion in the medium layer, and sm3 as inva-
sion in the deep layer. Lymphatic vessel invasion (LVI) was
regarded as definite when cancer cells were detected in the thin-
walled endothelium-lined space containing no red blood cells but
occasionally containing lymph fluid (Sarbia et al, 1995) (Figure
2A). Blood vessel invasion (BVI) was defined as tumour cells and
red blood cells within the round or ovoid endothelium-lined spaces
with a smooth muscle layer (Theunissen et al, 1991; Inoue et al,
1992; Sarbia et al, 1995). The presence of an adjacent artery aided
in detecting vascular invasion (Inoue et al, 1992) (Figure 2B).
Intramural metastasis (IM) was defined as a metastatic tumour
within the oesophageal wall which was separate from the primary
tumour, not located within a vessel lumen but rather observed to
invade the oesophageal stroma and not accompanied by an
intraepithelial cancerous lesion (Takubo et al, 1990; Kuwano et al,
1994) (Figure 2C).
Follow-up
None of the 78 patients died within 30 days of the operation or
during their hospital stay. All patients were followed up regularly
at our institution or at affiliated hospitals with routine physical and
laboratory examination after discharge. Follow-up examinations,
such as computed tomography, ultrasonography and upper GI
series were carried out every 3 or 6 months. Endoscopic examina-
tions were performed when appropriate. The progress of the
patients was monitored for more than 2 years after surgery.
Statistical analysis
The clinicopathological parameters included age, sex, location of
the tumour, length of the tumour, histological differentiation,
subclassification of depth, lymphatic invasion, blood vessel inva-
sion, intramural metastasis and lymph node metastasis. The
survival rates were calculated by the Kaplan-Meiyer method and
statistically significant differences were analysed by the log-rank
test. Variables including age, location, length, differentiation,
subclassification of depth, vessel invasion (VI), IM and lymph
node metastasis (LN) were subjected to a multivariate analysis
using a proportional hazards model to identify any independent
predictors regarding the prognosis.
RESULTS
The survival curves of patients with superficial carcinoma of the
oesophagus are shown in Figure 1. The three- and five-year
survival rates of 78 patients with sm carcinoma were 80.8% and
74.3%, respectively, and were lower than those with either intra-
epithelial or mucosal carcinoma (statistically not significant).
The clinicopathologic factors and prognosis for patients with sm
carcinoma of the oesophagus are shown in Table 1. No significant
difference in the survival rates was observed between the groups
divided according to age, sex, location of the tumour, length of the
tumour, histological differentiation and subclassification of depth.
There were 17 cases (21.8%) with LVI, 7 cases (9.0%) with BVI
and 4 cases (5.1%) with IM. LN was recognized in 24 cases
(30.8%). Significant differences were observed in the survival
rates between the groups with LVI (P = 0.0003), IM (P = 0.0051)
and LN (P = 0.0026). Although there was no significant difference
between the groups with and without BVI, the three-year survival
rate of patients with BVI was no more than 50%. Then we exam-
ined the survival curves between the patients with and without VI.
As a result, the three- and five-year survival rates of the patients
with VI were 50.9% and 45.3%, respectively, while those without
VI were 95.9% and 89.3%, respectively. There was a significant
difference between these groups (P < 0.0001).
A multivariate analysis on factors including age (≤ 70), location
(upper), length (≤ 3.6 cm), differentiation (poorly), subclassifica-
tion of depth (sm3), VI (positive), IM (positive) and LN (positive)
was shown in Table 2. As a result, IM (P = 0.0038, relative risk
9.17), VI (P = 0.0033, relative risk 6.25) and LN (P = 0.0187, rela-
tive risk 3.62) were found to be significant factors. A total of 15
patients died of recurrent carcinoma after an oesophagectomy for
sm carcinoma in this series. The site of recurrence and the state of
VI, IM and LN are shown in Table 3. There were 14 of 15 cases
(93.3%) with at least one of these factors. These results also indi-
cated the prognostic significance of VI, IM and LN. We next
compared the survival curves between the cases with none of VI,
IM and LN (Group I) and the others (Group II) (Figure 3A), and
between the cases with neither VI nor IM (Group III) and the
others (Group IV) (Figure 3B). Significant differences were
observed between Groups I and II (P = 0.002), and between
Groups III and IV (P < 0.0001). The five-year survival rate of
Group I patients was as good as that of mucosal carcinoma of the
oesophagus.
DISCUSSION
The number of patients with superficial carcinoma of the oesoph-
agus has recently been increasing in Japan (Sugimachi et al, 1989;
Yoshinaka et al, 1991). In our department, there were 397 patients
with oesophageal carcinoma who had undergone an oesophagec-
tomy over the last decade and 116 of them (29.2%) had superficial
carcinoma, while there were only 39 of 364 cases (10.7%) before
610 M Watanabe et al
British Journal of Cancer (2000) 83(5), 609–613 © 2000 Cancer Research Campaign
Time after operation (years)
04 5 2 13
60
50
70
80
90
100
74.3%
80.8%
Submucosal cancer (n=78)
Mucosal cancer (n=32)
Epithelial cancer (n=6)
95.2% 95.2%
100%
S
u
r
v
i
v
a
l
 
r
a
t
e
 
(
%
)
Figure 1 Survival of the patients with superficial carcinoma of the
oesophagus (1988–1997, Department of Surgery II, Kyushu University
Hospital).this period (data not shown). Regarding the reason for the
increased incidence, many authors have pointed out the recent
trends in the frequent use of panendoscopy, especially in asympto-
matic patients, and also the use of Lugol’s solution staining tech-
nique (Shimizu et al, 1983; Schmidt et al, 1986; Bogomoletz et al,
1989; Sugimachi et al, 1989). Cases with sm carcinoma are
reported to amount to approximately 70% of all patients with
superficial carcinoma of the oesophagus (Yoshinaka et al, 1991).
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Table 1 Clinicopathological parameters and suvival analysis for patients with submucosal carcinoma of the oesophagus
Factors Cases (%) Survival rate (%) P value
1 yr 2 yr 3 yr 4 yr 5 yr
Age ≤ 59 30 (38.5) 96.6 85.8 77.8 77.8 72.9 0.6084
60–69 30 (38.5) 96.7 89.1 85.0 85.0 85.0
≥ 70 18 (23.0) 94.4 87.2 78.5 69.7 58.1
Sex Male 74 (94.9) 95.8 86.6 80.0 78.1 73.5 N.S.
Female 4 (5.1) 100 100 100 100 100
Location Upper 12 (15.4) 90.9 77.9 77.9 77.9 58.4 0.8416
Middle 41 (52.6) 97.4 89.1 83.0 79.4 75.4
Lower 25 (32.1) 96.0 88.0 78.2 78.2 78.2
Length >3.6 cm 48 (61.5) 97.9 88.3 82.8 82.8 74.7 0.6431
≤ 3.6 cm 30 (38.5) 93.0 85.3 77.2 72.9 72.9
Differentiation Well 8 (10.3) 100 100 100 100 80.0 0.9978
of SCCa Modb 45 (57.7) 93.1 88.0 82.6 79.3 75.1
Poorb 20 (25.6) 100 79.2 73.5 73.5 73.5
Others 5 (6.4)
Subclassification sm1 15 (19.2) 93.3 93.3 84.0 84.0 84.0 0.1627
of depthc sm2 27 (34.6) 96.3 91.5 91.5 91.5 84.9
sm3 36 (46.2) 97.2 82.3 72.6 69.2 64.6
Lymphatic Negative 61 (78.2) 100 94.3 90.0 87.4 84.4 0.0003
invasion Positive 17 (21.8) 82.4 63.7 51.0 51.0 42.5
Blood vessel Negative 71 (91.0) 95.7 87.7 84.1 82.0 76.8 0.1845
invasion Positive 7 (9.0) 100 83.3 50.0 50.0 50.0
Intramural Negative 74 (94.9) 97.3 87.9 82.7 80.7 78.3 0.0051
metastasis Positive 4 (5.1) 75.0 75.0 50.0 50.0 0
Lymph node Negative 54 (69.2) 100 95.6 88.4 85.7 82.6 0.0026
metastasis Positive 24 (30.8) 87.1 68.9 64.0 64.0 54.8
aSCC, Squamous cell carcinoma. bMod, moderately; Poor, poorly. csm1, one-third invasion in the superficial submucosal layer; sm2, one-third
invasion in the medium layer; sm3, one-third invasion in the deep layer.
Figure 2 (A) Lymphatic vessel invasion (× 70): the cancer cells were
detected in the thin walled endothelium-lined space containing no red blood
cells but containing lymph fluid. (B) Blood vessel invasion (× 100): the tumour
cells and red blood cells within the round or ovoid endothelium-lined spaces
with a smooth muscle layer. An adjacent artery is recognized. (C) Intramural
metastasis (× 38): the metastatic tumour within the esophageal wall which
was separate from the primary tumour, and not located within a vessel lumen
but rather observed to invade the oesophageal stroma, and not accompanied
by an intraepithelial cancerous lesion.
A
B
CThe long-term survival of patients with sm carcinoma of the
oesophagus has been reported to be significantly poorer than those
with intraepithelial or mucosal carcinoma (Sugimachi et al, 1989,
1993). Regarding the poor prognosis, the well-developed intra-
mural lymphatic network of the oesophagus, especially in the sm
layer, and consequently frequent lymph node involvement have
been pointed out (Akiyama et al, 1994b). Therefore, a subtotal
oesophagectomy with extended lymph node dissection, as is
usually performed for advanced cancer, has been recommended
(Yoshinaka et al, 1991; Kato et al, 1993; Watanabe et al, 1995).
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Figure 3 Survival of the patients with submucosal carcinoma of the oesophagus. (A) Group I, patients with none of vessel invasion, intramural metastasis and
lymph node metastasis; Group II, patients with at least one of these factors. (B) Group III, patients with either vessel invasion nor intramural metastasis; Group
IV, patients with either vessel invasion or intramural metastasis. A significant difference was observed in the survival between Groups I and II (P = 0.002), and
Groups III and IV (P < 0.0001).
Table 2 A multivariate analysis
Variable Coefficient Standard Relative risk P value
error
Intramural metastasis (positive) 2.221 0.768 9.17 0.0038
Vessel invasion (positive) 1.831 0.624 6.25 0.0033
Lymph node metastasis (positive) 1.287 0.547 3.62 0.0187
Subclassification of depth (sm3) 0.678 0.623 1.97 0.2763
Age (≤ 70) 0.628 0.679 1.87 0.3555
Length (≤ 3.6 cm) 0.571 0.565 1.77 0.3128
Location (upper) 0.153 0.807 1.16 0.8499
Differentiation of SCCa (poorly) 0.054 0.564 1.05 0.9240
aSCC, squamous cell carcinoma.
Table 3 Survival period and site of recurrence in cases with submucosal carcinoma of the oesophagus
Case Age Sex Survival Site of Lymphatic Blood vessel Intramural Lymph node
period recurrence invasion invasion metastasis recurrence
1 77 M 4M Lung + –– +
2 51 M 9M Surgical margin + –– +
3 63 M 10M Lung, bone + + + +
4 59 M 1Y 1M Mediastinal LNa + –– +
5 56 M 1Y 6M Liver + –– –
6 76 M 1Y 7M Surgical margin ––– +
7 62 M 1Y10M Mediastinal LNa – + ––
8 69 M 2Y Cervical LNa + –– +
9 73 M 2Y 2M Hilar LNa – + ––
10 61 M 2Y 2M Lung – ++ –
11 47 M 2Y11M Abdominal LNa + –– –
12 71 M 3Y 3M Liver ––– –
13 70 M 3Y 4M Surgical margin + –– +
14 58 M 4Y Surgical margin –– + –
15 60 M 6Y10M Lung ––– +
aLymph node.Owing to these efforts, an improved survival rate has begun to
be reported. The 5-year survival rate of patients with sm carcinoma
was 74% in our series, which was as good as that noted in other
recent reports in Japan (Yoshinaka et al, 1991; Kato et al, 1993;
Watanabe et al, 1995). Nevertheless, there were more than a few
patients who died of recurrent carcinoma after a curative
oesophagectomy, as shown in Table 3. In these patients, the carci-
noma has already spread beyond a surgically resectable area at the
time of the operation, and it is thus impossible to cure them by
radical surgery alone. The aim of this study was to clarify the
factors concerning recurrence after a curative oesophagectomy for
patients with sm carcinoma of the oesophagus in order to select the
patients who had a high risk of recurrence. As a result, VI, IM and
LN were proven to be significant prognostic factors by the Cox
regression analysis.
Lymph node metastasis is known to be an important cause of
death in cancer of the oesophagus. There have also been several
reports on the prognostic significance of lymph node metastasis in
superficial carcinoma of the oesophagus (Yoshinaka et al, 1991;
Nishimaki et al, 1998; Matsubara et al, 1999). In this study, the
survival of patients with LN was significantly poorer than that
without, and LN was identified as one of the independent prog-
nostic factors. On the other hand, although the prognostic signifi-
cance of VI or IM in squamous cell carcinoma of the oesophagus
has been reported previously (Takubo et al, 1990; Theunissen et al,
1991; Kuwano et al, 1994; Sarbia et al, 1995), few reports have
shown the significance of them in sm carcinoma. In this study, we
revealed that these factors were also independent prognostic
factors. The question then arises about the rate of VI in sm carci-
noma of the oesophagus that varies according to the articles. A
higher rate was reported by Nishimaki et al (1994), 16 of 27 cases
(59.3%), and by Nabeya and Nakata (1997), LVI in 701 of 1225
cases (57.2%) and BVI in 311 of 1225 cases (25.4%). While
Sarbia et al reported that 12 cases (28.6%) with LVI and 4 cases
(9.5%) with BVI were found in 42 cases with pT1/T2 carcinoma
(1995). In our series, the rate was closer to the latter. Such varia-
tion is probably caused by differences in the criteria for deter-
mining VI. We have diagnosed all cases according to the
above-described criteria and confirmed the usefulness of such
criteria for predicting the prognosis.
Finally, we shall discuss the indication for adjuvant therapy after
surgery. As shown in Figure 3A, the survival of Group I was
significantly better than that of Group II, and 5-year survival rate
of Group I patients was as good as that of mucosal cancer.
However, the difference of the prognosis between Groups III and
IV, shown in Figure 3B, was more significant than that between
Groups I and II, and there were 14 of 40 patients (35.0%) who died
of recurrent cancer within 5 years in Group II while there were 12
of 26 (46.2%) in Group IV. For reasons mentioned above, we may
say that Group IV patients, i.e. patients with either VI or IM, are
candidates for adjuvant therapy.
In conclusion, based on the above findings, VI, IM and LN are
thus considered to be significant prognostic factors in patients with
sm carcinoma of the oesophagus. In order to improve the prog-
nosis of sm carcinoma of the oesophagus, we still need to identify
the optimal adjuvant therapy for patients with either VI or IM posi-
tive sm carcinoma of the oesophagus.
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